Legislation makers, in addition to other stakeholders in society, may very well be skeptical about re-dispensing returned medicines with out appropriate validation [sixteen]. This portion describes how hottest technologies gathered from the literature critique can help the reuse of returned medicines in accordance with the two groups of stakeholder